Internal Medicine, Endocrinology, Diabetes, & Metabolism · Sycamore, IL
NPI
1962692418
Since 2007
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
1850 Gateway Dr
Sycamore, IL, 60178
Phone (815) 754-1097
Groups this clinician bills Medicare through
Medicare paid, 2024
$109K
2,384 services
Medicare patients, 2024
507
Average age 71
Drug cost, 2024
$3.5M
5,831 prescriptions
Company payments, 2025
$426
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Wendell R Malalis was code J0897 (injection, denosumab, 1 mg), 1,140 times for 13 patients. In total Wendell R Malalis billed 2,384 services in 19 codes, and Medicare paid $109K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-05-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 1,140 | 13 | $20.77 | $24K |
| 99214 Office E&M - Established | Office | 603 | 400 | $90.71 | $55K |
| 95251 Test - Miscellaneous | Office | 215 | 128 | $26.48 | $5,693 |
| 83036 Blood Count | Office | 147 | 121 | $9.52 | $1,399 |
| 99204 Office E&M - New | Office | 65 | 65 | $117.41 | $7,631 |
| 99223 Hospital E&M - Initial | Facility | 40 | 37 | $138.70 | $5,548 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 33 | 32 | $11.00 | $363 |
| 99232 Hospital E&M - Subsequent | Facility | 29 | 19 | $63.17 | $1,832 |
| 96372 Injection Administration | Office | 18 | 13 | $11.17 | $201 |
| 99443 Telephone Services | Office | 15 | 15 | $60.75 | $911 |
| 90662 Vaccine Product | Office | 13 | 13 | $81.06 | $1,054 |
| G0008 Administration of influenza virus vaccine | Office | 13 | 13 | $31.15 | $405 |
| 99291 Critical Care E&M | Facility | 12 | 11 | $172.07 | $2,065 |
By year: 2022 $97K for 1,983 services; 2023 $100K for 2,087 services; 2024 $109K for 2,384 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 147 | 121 | $9.52 | $1,399 |
Medicare prescription drug claims, 2024
In 2024, the drug Wendell R Malalis prescribed most often to Medicare patients was Levothyroxine Sodium, with 858 prescriptions and refills. In total Wendell R Malalis wrote 5,831 Medicare prescriptions that cost $3.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 858 | 2,230 | 240 | $8,630 |
| Ozempic Semaglutide | 545 | 1,123 | 165 | $1.1M |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 385 | 884 | 146 | $59K |
| Metformin Hcl Generic | 294 | 764 | 105 | $3,008 |
| Metformin Hcl Er Metformin Hcl | 281 | 681 | 93 | $2,507 |
| Jardiance Empagliflozin | 211 | 506 | 69 | $295K |
| Trulicity Dulaglutide | 200 | 319 | 45 | $307K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 195 | 548 | 88 | $26K |
| Glimepiride Generic | 169 | 461 | 55 | $1,402 |
| Tresiba Flextouch U-100 Insulin Degludec | 161 | 435 | 59 | $168K |
| Humalog Kwikpen U-100 Insulin Lispro | 158 | 366 | 67 | $66K |
| Novolog Flexpen Insulin Aspart | 152 | 315 | 56 | $61K |
| Basaglar Kwikpen U-100 Insulin Glargine,hum.Rec.Anlog | 146 | 307 | 54 | $96K |
| Synthroid Levothyroxine Sodium | 140 | 363 | 37 | $14K |
| Mounjaro Tirzepatide | 104 | 154 | 29 | $164K |
Brand drugs: 3,541 claims; generic drugs: 1,750 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Wendell R Malalis $426 ($426 in general payments such as food, travel and fees) from 5 companies. The largest payer was Boston Scientific Corporation with $170.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.